Publicacions en col·laboració amb investigadors/es de Centro de Investigación Biomédica en Red de Cáncer (8)

2024

  1. Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary Cancer

    International Journal of Molecular Sciences, Vol. 25, Núm. 4

  2. PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2− breast cancer

    Cancer Medicine, Vol. 13, Núm. 17

  3. Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer

    Oncogenesis, Vol. 13, Núm. 1

2023

  1. Analysis of Circulating Tumor DNA in Synchronous Metastatic Colorectal Cancer at Diagnosis Predicts Overall Patient Survival

    International Journal of Molecular Sciences, Vol. 24, Núm. 9

2021

  1. MZ1 co-operates with trastuzumab in HER2 positive breast cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

2020

  1. Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple-negative breast cancer

    Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 5, pp. 3117-3127

2019

  1. Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1

2017

  1. Regulation of the prometastatic neuregulin–MMP13 axis by SRC family kinases: therapeutic implications

    Molecular Oncology, Vol. 11, Núm. 12, pp. 1788-1805